Correction
Accepted on 30 Sep 2025
Correction: CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1715691
Type at least 3 characters
264 articles
Mini Review
Published on 25 Sep 2025
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1647028
- 1,078 views
Original Research
Accepted on 22 Sep 2025
Relationship between hemoglobin glycation index and Cushing's syndrome: a cross-sectional study in Chinese populations
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1678472
- 604 views
Original Research
Accepted on 22 Sep 2025
Morning Serum Cortisol as a Predictor of Synacthen Stimulation Test Outcomes During Corticosteroid Withdrawal: A Comparative Analysis of High-Dose and Low-Dose Protocols
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1655146
- 572 views
Original Research
Published on 19 Sep 2025
The aldosteronoma resolution score predicts the prognosis of hypertension under two surgical procedures
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1651381
- 2,704 views
Original Research
Accepted on 17 Sep 2025
Germline targeted next-generation sequencing in patients with adrenal incidentalomas
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1685220
- 594 views
Original Research
Accepted on 10 Sep 2025
Primary Adrenal Lymphoma and Its Mimics: Clinico-Radiological Differential Diagnosis
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1639878
- 998 views
Correction
Published on 10 Sep 2025
Correction: Pheochromocytoma metastasis to the central nervous system: a case report and systematic review
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1694463
- 1,332 views
Original Research
Published on 09 Sep 2025
Optimizing glucocorticoid therapy in congenital adrenal hyperplasia and analog conditions: the intersection of dose reduction, patient care, and coverage in the US
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1603701
- 1,269 views
Original Research
Published on 29 Aug 2025
Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronism
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1558837
- 1,237 views
Systematic Review
Published on 25 Aug 2025
Pheochromocytoma metastasis to the central nervous system: a case report and systematic review
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1633411
- 2,094 views
Original Research
Published on 22 Aug 2025
Arterial stiffness and shortened QTc interval are associated with androgen and ACTH levels in classic congenital adrenal hyperplasia
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1660114
- 1,345 views
Original Research
Published on 22 Aug 2025
Insights into genetic and clinical profiles of triple A syndrome in Sudanese children
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1617552
- 1,359 views
Original Research
Published on 29 Jul 2025
High prevalence but low referral rate of adrenal incidentalomas in a Lebanese tertiary hospital
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1598685
- 949 views
Original Research
Published on 24 Jul 2025
A predictive nomogram for incomplete clinical success after unilateral adrenalectomy in patients with primary aldosteronism
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1628564
- 1,229 views
Original Research
Published on 17 Jul 2025
Clinical value of sublingual microcirculatory dysfunction for screening for primary aldosteronism in hypertensive patients
in Adrenal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1561503
- 1,303 views